MITSUBISHI PHARMA CORPORATION
Patent Owner
Stats
- 65 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Oct 12, 2017 most recent publication
Details
- 65 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,064 Total Citation Count
- Jun 05, 1980 Earliest Filing
- 160 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8324283 Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcoholAug 11, 08Dec 04, 12[A61K, A01N]
7211596 Stable high-concentration injection containing pyrazolone derivativeMay 09, 02May 01, 07[A61K]
7198921 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced therebyMay 16, 01Apr 03, 07[C12P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0217,723 Pharmaceutical Composition Combining Tenatoprazole and an Anti-Inflammatory AgentAbandonedMar 25, 13Aug 22, 13[A61K]
2012/0122,919 PHARMACEUTICAL COMPOSITION COMBINING TENATOPRAZOLE AND A HISTAMINE H2-RECEPTOR ANTAGONISTAbandonedNov 15, 11May 17, 12[A61K, A61P]
2011/0152,314 USE OF TENATOPRAZOLE FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASEAbandonedFeb 25, 11Jun 23, 11[A61K, A61P]
2010/0048,518 Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agentAbandonedOct 27, 09Feb 25, 10[A61K, A61P]
7507743 Substituted 8′-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one derivativesExpiredOct 02, 07Mar 24, 09[A61K, A61P]
2009/0005,392 CRYSTAL OF 6-[4-(4-PYRIDYLAMINO) PHENYL]-4,5-DIHYDRO-3(2H-PYRIDAZINONE HYDROCHLORIDE TRIHYDRATEAbandonedFeb 11, 08Jan 01, 09[A61K, C07D, A61P]
2008/0318,980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORSAbandonedAug 20, 08Dec 25, 08[A61K, A61P]
7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivativesExpiredMay 16, 07Dec 16, 08[A61K]
7462621 Use of substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives as therapeutic agentsExpiredApr 05, 07Dec 09, 08[C07D]
7452897 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseasesExpiredMar 29, 07Nov 18, 08[A61K]
7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3.beta. inhibitorsExpiredFeb 26, 03Sep 30, 08[C07D]
7393853 Use of substituted 8-Perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives as therapeutic agentsExpiredApr 04, 07Jul 01, 08[A61K]
7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disordersExpiredSep 19, 02Jun 17, 08[A61K]
7312239 Medicament for prevention and/or therapy of arterial wall disorderExpiredAug 18, 03Dec 25, 07[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
